2,397
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Crataegus Aronia protects and reverses vascular inflammation in a high fat diet rat model by an antioxidant mechanism and modulating serum levels of oxidized low-density lipoprotein

, , , , , & show all
Pages 37-47 | Received 16 Sep 2018, Accepted 19 Dec 2018, Published online: 31 Jan 2019

References

  • Al-Hallaq EK, Afifi FU, Abdalla SS. 2012. Evaluation of the hypocholesterolemic effect and phytochemical screening of the hydroethanolic extract of Crataegus aronia from Jordan. Nat Prod Commun. 7:35–38.
  • Anogeianaki A, Angelucci D, Cianchetti E, D'Alessandro M, Maccauro G, Saggini A, Salini V, Caraffa A, Tete S, Conti F. 2011. Atherosclerosis: a classic inflammatory disease. Int J Immunopathol Pharmacol. 24:817–825.
  • Bach LA, Cooper ME, O'Brien RC, Jerums G. 1990. The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis. J Am Geriatr Soc. 38:10–14.
  • Balkan J, Oztezcan S, Aykaç-Toker G, Uysal M. 2002. Effects of added dietary taurine on erythrocyte lipids and oxidative stress in rabbits fed a high cholesterol diet. Biosc Biotech Biochem. 66:2701–2705.
  • Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. 1990. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 65:297–302.
  • Bassuk SS, Rifai N, Ridker PM. 2004. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 29:439–493.
  • Besler C, Lüscher TF, Landmesser U. 2012. Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease. EMBO Mol Med. 4:251–268.
  • Bondar KY, Belaya OL, Lazutina OM, Kuropteva ZV, Raider LM, Artamoshina NE, Yakovleva TV. 2012. Atorvastatin and oxidative stress in coronary heart disease with obesity. Klin Med (Mosk). 90:34–38.
  • Cai H, Harrison DG. 2000. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Res. 87:840–844.
  • Cave A. 2009. Selective targeting of NADPH oxidase for cardiovascular protection. Curr Opinion Pharmacol. 9:208–213.
  • Chang WT, Dao J, Shao ZH. 2005. Hawthorn: potential roles in cardiovascular disease. Am J Chin Med. 33:1–10.
  • Chu C-Y, Lee M-J, Liao C-L, Lin W-L, Yin Y-F, Tseng T-H. 2003. Inhibitory effect of hot-water extract from dried fruit of Crataegus pinnatifida on low-density lipoprotein (LDL) oxidation in cell and cell-free systems. J Agric Food Chem. 51:7583–7588.
  • Crespo M, Quidgley J. 2015. Simvastatin, atorvastatin, and pravastatin equally improve the hemodynamic status of diabetic rats. World J Diabetes. 6:1168–1178.
  • Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 87:5134–5138.
  • Devaraj S, Du Clos TW, Jialal I. 2005. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol. 25:1359–1363.
  • Devaraj S, Singh U, Jialal I. 2009. The evolving role of C-reactive protein in atherothrombosis. Clin Chem. 55:229–238.
  • Durrington PN, Mackness B, Mackness MI. 2001. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol. 21:473–480.
  • Escobar C, Echarri R, Barrios V. 2008. Relative safety profiles of high dose statin regimens. Vasc Health Risk Manag. 4:525–533.
  • Forstermann U, Munzel T. 2006. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 113:1708–1714.
  • Freire RD, Cardoso MA, Gimeno SG, Ferreira SR. 2005. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care. 28:1779–1785.
  • Frostegård J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. 1992. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol. 12:461–467.
  • Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. 1995. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci. 748:501–507.
  • Galkina E, Ley K. 2007. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol. 27:2292–2301.
  • Girn HRS, Orsi NM, Homer-Vanniasinkam S. 2007. An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease. Vasc Med. 12:299–309.
  • Hashizume M, Hayakawa N, Mihara M. 2008. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology (Oxford). 47:1635–1640.
  • Huijgen R, Vissers MN, Defesche JC, Lansberg PJ, Kastelein JJ, Hutten BA. 2008. Familial hypercholesterolemia: current treatment and advances in management. Expert Rev Cardiovasc Ther. 6:567–581.
  • Humayed S. 2017. Protective and therapeutic effects of Crataegus aronia in non-alcoholic fatty liver disease. Arch Physiol Biochem. 123:1–8.
  • Khalil R, Abuharfeil N, Shabsoug B. 2008. The effect of Crataegus aronica aqueous extract in rabbits fed with high cholesterol diet. Eur J Sci Res. 22:352–360.
  • Klouche M, Rose-John S, Schmiedt W, Bhakdi S. 2000. Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation. 101:1799–1805.
  • Lecumberri E, Goya L, Mateos R, Alia M, Ramos S, Izquierdo-Pulido M, Bravo L. 2007. A diet rich in dietary fiber from cocoa improves lipid profile and reduces malondialdehyde in hypercholesterolemic rats. Nutrition. 23:332–341.
  • Li J, Sun YM, Wang LF, Li ZQ, Pan W, Cao HY. 2010. Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease. Clin Cardiol. 33:222–227.
  • Libby P. 2006. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 83:456S–460S.
  • Ljubuncic P, Portnaya I, Cogan U, Azaizeh H, Bomzon A. 2005. Antioxidant activity of Crataegus aronia aqueous extract used in traditional Arab medicine in Israel. J Ethnopharmacol. 101:153–161.
  • Loppnow H, Libby P. 1990. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin-6. J Clin Invest. 85:73–78.
  • Mackness MI, Arrol S, Durrington PN. 1991. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286:152–154.
  • Melo AC, Valença SS, Gitirana LB, Santos JC, Ribeiro ML, Machado MN, Magalhães CB, Zin WA, Porto LC. 2013. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury. Int Immunopharmacol. 17:57–64.
  • Meng S, Cao J, Feng Q, Peng J, Hu Y. 2013. Roles of chlorogenic acid in regulating glucose and lipids metabolism: a review. Evid Based Complement Altern Med. 2013:1. ID 801457.
  • Moreno LA, Rodríguez G. 2007. Dietary risk factors for development of childhood obesity. Curr Opin Clin Nutr Metab Care. 10:336–341.
  • Nikolic T, Zivkovic V, Srejovic I, Stojic I, Jeremic N, Jeremic J, Radonjic K, Stankovic S, Obrenovic R, Djuric D, et al. 2018. Effects of atorvastatin and simvastatin on oxidative stress in diet-induced hyperhomocysteinemia in Wistar albino rats: a comparative study. Mol Cell Biochem. 437:109–118.
  • Raffray L, Giry C, Thirapathi Y, Reboux A-H, Jaffar-Bandjee M-C, Gasque P. 2017. Increased levels of soluble forms of E-selectin and ICAM-1 adhesion molecules during human leptospirosis. PLoS One. 12:e0180474.
  • Romero AL, West KL, Zern T, Fernandez ML. 2002. The seeds from Plantago ovata lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs. J Nutr. 132:1194–1198.
  • Rosklint T, Ohlsson BG, Wiklund O, Noren K, Hulten LM. 2002. Oxysterols induce interleukin-1beta production in human macrophages. Eur J Clin Invest. 32:35–42.
  • Sawada M, Suzumura A, Marunouchi T. 1992. TNF alpha induces IL-6 production by astrocytes but not by microglia. Brain Res. 583:296–299.
  • Schulz E, Munzel T. 2008. NOX5, a new “radical” player in human atherosclerosis? J Am Coll Cardiol. 52:1810–1812.
  • Sedigheh A, Jamal MS, Mahbubeh S, Somayeh K, Mahmoud RK, Azadeh A, Fatemeh S. 2011. Hypoglycemic and hypolipidemic effects of pumpkin (Cucurbita pepo L.) on alloxan-induced diabetic rats. Afr J Pharm Pharmacol. 5:2620–2626.
  • Shatoor AS. 2011. Acute and sub-acute toxicity of Crataegus aronia syn. azarolus (L.) whole plant aqueous extract in Wistar rats. Am J Pharmacol Toxicol. 6:37–45.
  • Shatoor AS. 2013. In vivo hemodynamic and electrocardiographic changes following Crataegus aronia syn. azarolus L administration to normotensive Wistar rats. Saudi Med J. 34:123–134.
  • Shatoor AS, Soliman H, Al-Hashem F, Gamal BE, Othman A, El-Menshawy N. 2012. Effect of hawthorn (Crataegus aronia syn. azarolus (L)) on platelet function in albino Wistar rats. Thrombosis Res. 130:75–80.
  • Spindler SR, Li R, Dhahbi JM, Yamakawa A, Mote P, Bodmer R, Ocorr K, Williams RT, Wang Y, Ablao KP. 2012. Statin treatment increases lifespan and improves cardiac health in Drosophila by decreasing specific protein prenylation. PLoS One. 7:e39581.
  • Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler E, Najjar SS, Rembold WS. 2008. Post-use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 21:93–111.
  • Stokes KY, Calahan L, Russell JM, Gurwara S, Granger DN. 2006. Role of platelets in hypercholesterolemia-induced leukocyte recruitment and arteriolar dysfunction. Microcirculation. 13:377–388.
  • Tavori H, Aviram M, Khatib S, Musa R, Nitecki S, Hoffman A, Vaya J. 2009. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med. 46:607–615.
  • Thakore AH, Guo C-Y, Larson MG, Corey D, Wang TJ, Vasan RS, D’Agostino RB, Lipinska I, Keaney JF, Benjamin EJ, et al. 2007. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol. 99:1598–1602.
  • Tuzcu M, Sahin N, Orhan C, Agca CA, Akdemir F, Tuzcu Z, Komorowski J, Sahin K. 2011. Impact of chromium histidinate on high fat diet induced obesity in rats. Nutr Metab (Lond). 8:1–8.
  • Verma S, Devaraj S, Jialal I. 2006. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. 113:2135–2150.
  • Voleti B, Agrawal A. 2006. Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist. Mol Immunol. 43:891–896.
  • Von der Thusen JH, Kuiper J, van Berke TJ, Biessen EA. 2003. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev. 55:133–166.
  • Young JL, Libby P, Schonbeck U. 2002. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost. 88:554–567.
  • Zcan M, HacIseferogullar H, Marakoglu T, Arslan D. 2005. Hawthorn (Crataegus spp.) fruit: some physical and chemical properties. J Food Eng. 69:409–413.
  • Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann KJ, Conn CA, Soszynski D, Grabiec C, Trumbauer ME, Shaw A. 1995. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity. 3:9–19.